COVID-19 update

Remaining Time

Suggestions
    Tablet device running BrainTrip app

    Creating affordable screening tools for dementia

    Problem
    Dementia affects more than 50 million people worldwide, with only a tiny fraction diagnosed and receiving care.
    Solution
    A fast and affordable way to screen for dementia, enabling early treatment.
    Sector
    • Healthcare
    Origin
    • Malta
    Presence
    • Malta
    • BrainTrip device
      About the company

      BrainTrip proposes a novel approach for early, fast, and affordable dementia screening based on electroencephalography (EEG). BrainTrip has developed, scientifically tested, and validated the BrainTrip Cognitive Index (BCI), an algorithm for the reliable detection of cognitive impairment, which can be the result of early-stage dementia. Our product is a piece of software compatible with existing, inexpensive, and portable EEG devices that we source and supply to hospitals, nursing homes, and other health practitioners. The test is based on brainwave analysis and enables early dementia detection, which leads to early treatment.

    test
    For inquiries please contact us
    Get in touch